CLDI
Price
$0.72
Change
+$0.13 (+22.03%)
Updated
Jul 21, 03:55 PM (EDT)
Capitalization
20.49M
RYTM
Price
$88.13
Change
-$1.07 (-1.20%)
Updated
Jul 21, 04:40 PM (EDT)
Capitalization
5.89B
15 days until earnings call
Interact to see
Advertisement

CLDI vs RYTM

Header iconCLDI vs RYTM Comparison
Open Charts CLDI vs RYTMBanner chart's image
Calidi Biotherapeutics
Price$0.72
Change+$0.13 (+22.03%)
Volume$550
Capitalization20.49M
Rhythm Pharmaceuticals
Price$88.13
Change-$1.07 (-1.20%)
Volume$1.3K
Capitalization5.89B
CLDI vs RYTM Comparison Chart in %
Loading...
CLDI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RYTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDI vs. RYTM commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDI is a Hold and RYTM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (CLDI: $0.59 vs. RYTM: $89.20)
Brand notoriety: CLDI and RYTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDI: 13% vs. RYTM: 82%
Market capitalization -- CLDI: $20.49M vs. RYTM: $5.89B
CLDI [@Biotechnology] is valued at $20.49M. RYTM’s [@Biotechnology] market capitalization is $5.89B. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDI’s FA Score shows that 0 FA rating(s) are green whileRYTM’s FA Score has 1 green FA rating(s).

  • CLDI’s FA Score: 0 green, 5 red.
  • RYTM’s FA Score: 1 green, 4 red.
According to our system of comparison, both CLDI and RYTM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDI’s TA Score shows that 6 TA indicator(s) are bullish while RYTM’s TA Score has 6 bullish TA indicator(s).

  • CLDI’s TA Score: 6 bullish, 4 bearish.
  • RYTM’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, RYTM is a better buy in the short-term than CLDI.

Price Growth

CLDI (@Biotechnology) experienced а -21.89% price change this week, while RYTM (@Biotechnology) price change was +2.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.79%. For the same industry, the average monthly price growth was +16.27%, and the average quarterly price growth was +35.62%.

Reported Earning Dates

RYTM is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (+2.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RYTM($5.89B) has a higher market cap than CLDI($20.5M). RYTM YTD gains are higher at: 59.343 vs. CLDI (-48.383). CLDI has higher annual earnings (EBITDA): -17.73M vs. RYTM (-145.8M). RYTM has more cash in the bank: 314M vs. CLDI (10.6M). RYTM has less debt than CLDI: RYTM (4.06M) vs CLDI (4.71M). RYTM has higher revenues than CLDI: RYTM (137M) vs CLDI (0).
CLDIRYTMCLDI / RYTM
Capitalization20.5M5.89B0%
EBITDA-17.73M-145.8M12%
Gain YTD-48.38359.343-82%
P/E RatioN/AN/A-
Revenue0137M-
Total Cash10.6M314M3%
Total Debt4.71M4.06M116%
FUNDAMENTALS RATINGS
RYTM: Fundamental Ratings
RYTM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
22
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLDIRYTM
RSI
ODDS (%)
Bearish Trend 4 days ago
17%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
48%
Bearish Trend 4 days ago
80%
Momentum
ODDS (%)
Bullish Trend 4 days ago
48%
Bullish Trend 4 days ago
74%
MACD
ODDS (%)
Bullish Trend 4 days ago
35%
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
73%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
32%
Bullish Trend 4 days ago
76%
Advances
ODDS (%)
Bullish Trend 12 days ago
51%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
34%
Bearish Trend 4 days ago
83%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
CLDI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RYTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAPL21.220.16
+0.76%
CrossAmerica Partners LP
BCS18.88-0.13
-0.68%
Barclays PLC
TDC21.59-0.21
-0.96%
TERADATA Corp
MAMA9.24-0.15
-1.60%
Mama's Creations
MOGU2.40-0.11
-4.38%
MOGU

CLDI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDI has been loosely correlated with DYN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDI jumps, then DYN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDI
1D Price
Change %
CLDI100%
-3.62%
DYN - CLDI
36%
Loosely correlated
-4.04%
VBIZF - CLDI
34%
Loosely correlated
N/A
LENZ - CLDI
32%
Poorly correlated
-2.43%
RYTM - CLDI
31%
Poorly correlated
-1.63%
IGMS - CLDI
30%
Poorly correlated
+0.39%
More

RYTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, RYTM has been loosely correlated with CRNX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if RYTM jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RYTM
1D Price
Change %
RYTM100%
-1.63%
CRNX - RYTM
46%
Loosely correlated
-5.78%
VRNA - RYTM
45%
Loosely correlated
+0.11%
IDYA - RYTM
44%
Loosely correlated
-2.26%
RVMD - RYTM
43%
Loosely correlated
-1.92%
DNLI - RYTM
43%
Loosely correlated
-3.65%
More